374 related articles for article (PubMed ID: 35905891)
1. Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis.
Li X; Li Q; Xiong B; Chen H; Wang X; Zhang D
Pharmacol Res; 2022 Sep; 183():106368. PubMed ID: 35905891
[TBL] [Abstract][Full Text] [Related]
2. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
[TBL] [Abstract][Full Text] [Related]
3. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
[TBL] [Abstract][Full Text] [Related]
4. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
[TBL] [Abstract][Full Text] [Related]
5. Decreased Expression of Cystathionine β-Synthase Exacerbates Intestinal Barrier Injury in Ulcerative Colitis.
Chen S; Zuo S; Zhu J; Yue T; Bu D; Wang X; Wang P; Pan Y; Liu Y
J Crohns Colitis; 2019 Aug; 13(8):1067-1080. PubMed ID: 30722010
[TBL] [Abstract][Full Text] [Related]
6. Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity.
Yu M; Wang Q; Ma Y; Li L; Yu K; Zhang Z; Chen G; Li X; Xiao W; Xu P; Yang H
Int J Biol Sci; 2018; 14(1):69-77. PubMed ID: 29483826
[TBL] [Abstract][Full Text] [Related]
7. Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response.
Wang Y; Liu J; Huang Z; Li Y; Liang Y; Luo C; Ni C; Xie J; Su Z; Chen J; Li C
Eur J Pharmacol; 2021 Apr; 896():173912. PubMed ID: 33508280
[TBL] [Abstract][Full Text] [Related]
8. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of Lizhong decoction on ulcerative colitis in mice by suppressing inflammation and ameliorating gut barrier.
Shen Y; Zou J; Chen M; Zhang Z; Liu C; Jiang S; Qian D; Duan JA
J Ethnopharmacol; 2020 Sep; 259():112919. PubMed ID: 32360800
[TBL] [Abstract][Full Text] [Related]
10. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
[TBL] [Abstract][Full Text] [Related]
11. Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice.
Yu XT; Xu YF; Huang YF; Qu C; Xu LQ; Su ZR; Zeng HF; Zheng L; Yi TG; Li HL; Chen JP; Zhang XJ
PLoS One; 2018; 13(3):e0194069. PubMed ID: 29538417
[TBL] [Abstract][Full Text] [Related]
12. SLC26A3 (DRA) prevents TNF-alpha-induced barrier dysfunction and dextran sulfate sodium-induced acute colitis.
Ding X; Li D; Li M; Wang H; He Q; Wang Y; Yu H; Tian D; Yu Q
Lab Invest; 2018 Apr; 98(4):462-476. PubMed ID: 29330471
[TBL] [Abstract][Full Text] [Related]
13. Isosteviol attenuates DSS-induced colitis by maintaining intestinal barrier function through PDK1/AKT/NF-κB signaling pathway.
Yao L; Chen X; Shen M; Zhao Y; Cao Q
Int Immunopharmacol; 2023 Jan; 114():109532. PubMed ID: 36508925
[TBL] [Abstract][Full Text] [Related]
14. Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies.
Raj V; Venkataraman B; Ojha SK; Almarzooqi S; Subramanian VS; Al-Ramadi BK; Adrian TE; Subramanya SB
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049744
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine alleviates intestinal barrier dysfunction and inflammatory response in mice via suppressing TLR4/MyD88/NF-κB signaling in an experimental model of ulcerative colitis.
Ye X; Xu H; Xu Y
Folia Histochem Cytobiol; 2022; 60(4):311-322. PubMed ID: 36504132
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol ameliorates ulcerative colitis by upregulating Nrf2/HO‑1 pathway activity: Integrating animal experiments and network pharmacology.
Yu X; Li X; Xu Y; Li Y; Zhou Y; Zhang J; Guo L
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38488031
[TBL] [Abstract][Full Text] [Related]
17. HO-1/CO Maintains Intestinal Barrier Integrity through NF-
Zhang Z; Zhang L; Zhang Q; Liu B; Li F; Xin Y; Duan Z
Oxid Med Cell Longev; 2021; 2021():6620873. PubMed ID: 34104309
[TBL] [Abstract][Full Text] [Related]
18. Luteolin alleviates ulcerative colitis through SHP-1/STAT3 pathway.
Li BL; Zhao DY; Du PL; Wang XT; Yang Q; Cai YR
Inflamm Res; 2021 Jun; 70(6):705-717. PubMed ID: 34014331
[TBL] [Abstract][Full Text] [Related]
19. In-Depth Study of Transmembrane Mucins in Association with Intestinal Barrier Dysfunction During the Course of T Cell Transfer and DSS-Induced Colitis.
Breugelmans T; Van Spaendonk H; De Man JG; De Schepper HU; Jauregui-Amezaga A; Macken E; Lindén SK; Pintelon I; Timmermans JP; De Winter BY; Smet A
J Crohns Colitis; 2020 Jul; 14(7):974-994. PubMed ID: 32003421
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function.
Cario E; Gerken G; Podolsky DK
Gastroenterology; 2007 Apr; 132(4):1359-74. PubMed ID: 17408640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
